Arca
Skip to content

Uterine fibroids

Drug research and approvals for uterine fibroids: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 16, 2026, 43 studies of uterine fibroids are recruiting on ClinicalTrials.gov, Health Canada has authorized 7 drug trials for it since 2013, and the EU has 2 authorised medicines for it.

  • Recruiting worldwide: 43
  • Trials authorized in Canada: 7
  • FDA orphan approvals: 0
  • EU medicines: 2

Recruiting Now

Newest start dates first, of 43 recruiting on ClinicalTrials.gov ↗

Trials Authorized in Canada

Newest first; search them all in Canada trials
Jun 7, 2017A randomized, parallel-group, double-blind, double-dummy, active-controlled, multicenter study to assess the efficacy and safety of vilaprisan in subjects with…VILAPRISAN (BAY-1002670)BayerClosed
Oct 27, 2016Extension study to evaluate the efficacy and safety of elagolix in premenopausal women with heavy menstrual bleeding associated with uterine fibroidsELAGOLIX (ABT-620)/ ESTRADIOL-NORETHINDRONEAbbVieClosed
Apr 29, 2016Treatment of uterine fibroids with magnetic resonance guided high intensity focused ultrasoundLEUPROLIDETHUNDER BAY REGIONAL RESEARCH INSTITUTEPending
Feb 23, 2016A phase 3 study to evaluate the efficacy and safety of elagolix in combination with estradiol/norethindrone acetate for the management of heavy menstrual…ELAGOLIX (ABT-620)/ ESTRADIOL-NORETHINDRONEAbbVieClosed
Feb 16, 2016A phase 3 study to evaluate the efficacy and safety of elagolix in combination with estradiol/norethindrone acetate for the management of heavy menstrual…ELAGOLIX (ABT-620)/ ESTRADIOL-NORETHINDRONEAbbVieClosed
May 13, 2014A randomized, parallel-group, double-blind, placebo-controlled, multi-center study to assess the efficacy and safety of different doses of bay 1002670 in…VILAPRISAN (BAY 1002670)BayerClosed
Jul 5, 2013A phase 2b study to evaluate the safety and efficacy of elagolix in premenopausal women with heavy menstrual bleeding associated with uterine fibroidsELAGOLIX (ABT-620)/ ESTRADIOL-NORETHINDRONEAbbVieClosed

Medicines Authorised in the EU

Newest first
Jun 14, 2022Yseltylinzagolix cholineTheramex Ireland LimitedEMA ↗
Jul 16, 2021Ryeqorelugolix;estradiol;norethisterone acetateGedeon Richter Plc.EMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.